FDA Rules, State Laws Stifle PrEP Research For Teens At Risk Of HIV

FDA regulations coupled with vague state laws have stifled research on the use of pre-exposure prophylaxis to combat HIV infections in adolescents -- who face higher HIV infection rates than other sectors of the population for which rates are declining, according to results of a new study and health care experts interviewed by Inside Health Policy . The following special report delves into how federal requirements and state regulatory barriers, coupled with unresolved ethical issues, have cast aside what the...